Polio
Research from the United Kingdom, Belgium and Japan in polio provides new insights
Published in Vaccine Weekly, October 18th, 2006
Study 1: Not all alternative polio immunization policies are cost effective in South Africa.
Researchers in England and South Africa conducted a study "to assess the cost-effectiveness of switching from oral polio vaccine (OPV) to inactivated poliovirus vaccine (IPV), or to cease polio vaccination in routine immunization services in South Africa at the time of OPV cessation globally following polio eradication."
"The cost-effectiveness of nine different polio immunization alternatives was evaluated. The costs of introducing IPV in a separate...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-10-18)
More Articles from Vaccine Weekly
- Measles Vaccine
One-dose measles vaccine may not provide long-term protection - Monkeypox Vaccine
Subunit recombinant vaccine protects against monkeypox - Pediatrics
Vaccine against ear infections may be in clinical trials by 2007 - Tuberculosis Vaccine
Influenza virus vectors expressing the Mycobacterium tuberculosis protein protect against tuberculosis - Alzheimer Disease Vaccine
Papillomavirus-like particles act as platform for Abeta immunization - Angiogenesis
Stem cell-like glioma cells promote tumor angiogenesis via growth factor - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
